Abstract
Ethylmalonic encephalopathy (EE) is a severe intoxication disorder caused by mutations in the ETHE1 gene that encodes a mitochondrial sulfur dioxygenase involved in the catabolism of hydrogen sulfide. It is biochemically characterized by tissue accumulation of hydrogen sulfide and its by-product thiosulfate, as well as of ethylmalonic acid due to hydrogen sulfide-induced inhibition of short-chain acyl-CoA dehydrogenase. Patients usually present with early onset severe brain damage associated to encephalopathy, chronic hemorrhagic diarrhea and vascular lesions with petechial purpura and orthostatic acrocyanosis whose pathophysiology is poorly known. Current treatment aims to reduce hydrogen sulfide accumulation, but does not significantly prevent encephalopathy and most fatalities. In this review, we will summarize the present knowledge obtained from human and animal studies showing that disruption of mitochondrial and redox homeostasis may represent relevant pathomechanisms of tissue damage in EE. Mounting evidence show that hydrogen sulfide and ethylmalonic acid markedly disturb critical mitochondrial functions and induce oxidative stress. Novel therapeutic strategies using promising candidate drugs for this devastating disease are also discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amaral AU et al (2012) Ethylmalonic acid impairs brain mitochondrial succinate and malate transport. Mol Genet Metab 105:84–90. https://doi.org/10.1016/j.ymgme.2011.10.006
Bhat MD, Prasad C, Tiwari S, Chandra SR, Christopher R (2016) Diffusion restriction in ethylmalonic encephalopathy—an imaging evidence of the pathophysiology of the disease. Brain Dev 38:768–771. https://doi.org/10.1016/j.braindev.2016.02.014
Bock FJ, Tait SWG (2020) Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol 21:85–100. https://doi.org/10.1038/s41580-019-0173-8
Boyer M, Sowa M, Di Meo I, Eftekharian S, Steenari MR, Tiranti V, Abdenur JE (2018) Response to medical and a novel dietary treatment in newborn screen identified patients with ethylmalonic encephalopathy. Mol Genet Metab 124:57–63. https://doi.org/10.1016/j.ymgme.2018.02.008
Bozi LHM, Campos JC, Zambelli VO, Ferreira ND, Ferreira JCB (2020) Mitochondrially-targeted treatment strategies. Mol Aspects Med 71:100836. https://doi.org/10.1016/j.mam.2019.100836
Burlina A et al (1991) New clinical phenotype of branched-chain acyl-CoA oxidation defect. Lancet 338:1522–1523. https://doi.org/10.1016/0140-6736(91)92338-3
Burlina AB et al (1994) A new syndrome with ethylmalonic aciduria and normal fatty acid oxidation in fibroblasts. J Pediatr 124:79–86. https://doi.org/10.1016/s0022-3476(94)70257-8
Cabral-Costa JV, Kowaltowski AJ (2020) Neurological disorders and mitochondria. Mol Aspects Med 71:100826. https://doi.org/10.1016/j.mam.2019.10.003
Cao X, Ding L, Xie ZZ, Yang Y, Whiteman M, Moore PK, Bian JS (2019) A review of hydrogen sulfide synthesis, metabolism, and measurement: is modulation of hydrogen sulfide a novel therapeutic for cancer? Antioxid Redox Signal 31:1–38. https://doi.org/10.1089/ars.2017.7058
Cardoso GMF et al (2017) Bioenergetics dysfunction, mitochondrial permeability transition pore opening and lipid peroxidation induced by hydrogen sulfide as relevant pathomechanisms underlying the neurological dysfunction characteristic of ethylmalonic encephalopathy. Biochim Biophys Acta 1863:2192–2201. https://doi.org/10.1016/j.bbadis.2017.06.007
Cecatto C, Amaral AU, Leipnitz G, Castilho RF, Wajner M (2014) Ethylmalonic acid induces permeability transition in isolated brain mitochondria. Neurotox Res 26:168–178. https://doi.org/10.1007/s12640-014-9460-5
da Rosa-Junior NT et al (2020) In vivo evidence that bezafibrate prevents oxidative stress and mitochondrial dysfunction caused by 3-methylglutaric acid in rat liver. Biochimie 171–172:187–196. https://doi.org/10.1016/j.biochi.2020.03.007
Dard L, Blanchard W, Hubert C, Lacombe D, Rossignol R (2020) Mitochondrial functions and rare diseases. Mol Aspects Med 71:100842. https://doi.org/10.1016/j.mam.2019.100842
de Moura AL et al (2019) Evidence that thiol group modification and reactive oxygen species are involved in hydrogen sulfide-induced mitochondrial permeability transition pore opening in rat cerebellum. Mitochondrion 47:141–150. https://doi.org/10.1016/j.mito.2018.11.001
Di Meo I, Fagiolari G, Prelle A, Viscomi C, Zeviani M, Tiranti V (2011) Chronic exposure to sulfide causes accelerated degradation of cytochrome c oxidase in ethylmalonic encephalopathy. Antioxid Redox Signal 15:353–362. https://doi.org/10.1089/ars.2010.3520
Di Meo I, Lamperti C, Tiranti V (2015) Mitochondrial diseases caused by toxic compound accumulation: from etiopathology to therapeutic approaches. EMBO Mol Med 7:1257–1266. https://doi.org/10.15252/emmm.201505040
Di Meo I, Lamperti C, Tiranti V (2017) Ethylmalonic encephalopathy. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A (eds) GeneReviews. University of Washington, Seattle
Dionisi-Vici C et al (2016) Liver transplant in ethylmalonic encephalopathy: a new treatment for an otherwise fatal disease. Brain 139:1045–1051. https://doi.org/10.1093/brain/aww013
Djouadi F, Bastin J (2019) Mitochondrial genetic disorders: cell signaling and pharmacological therapies. Cells. https://doi.org/10.3390/cells8040289
Eisner V, Picard M, Hajnoczky G (2018) Mitochondrial dynamics in adaptive and maladaptive cellular stress responses. Nat Cell Biol 20:755–765. https://doi.org/10.1038/s41556-018-0133-0
Enriquez JA (2016) Supramolecular organization of respiratory complexes. Annu Rev Physiol 78:533–561. https://doi.org/10.1146/annurev-physiol-021115-105031
Giordano C et al (2012) Morphologic evidence of diffuse vascular damage in human and in the experimental model of ethylmalonic encephalopathy. J Inherit Metab Dis 35:451–458. https://doi.org/10.1007/s10545-011-9408-3
Giorgi C, Missiroli S, Patergnani S, Duszynski J, Wieckowski MR, Pinton P (2015) Mitochondria-associated membranes: composition, molecular mechanisms, and physiopathological implications. Antioxid Redox Signal 22:995–1019. https://doi.org/10.1089/ars.2014.6223
Giorgi C, Marchi S, Pinton P (2018) The machineries, regulation and cellular functions of mitochondrial calcium. Nat Rev Mol Cell Biol 19:713–730. https://doi.org/10.1038/s41580-018-0052-8
Grings M et al (2013) Disturbance of brain energy and redox homeostasis provoked by sulfite and thiosulfate: potential pathomechanisms involved in the neuropathology of sulfite oxidase deficiency. Gene 531:191–198. https://doi.org/10.1016/j.gene.2013.09.018
Grings M, Parmeggiani B, Moura AP, de Moura AL, Wyse ATS, Wajner M, Leipnitz G (2018) Evidence that thiosulfate inhibits creatine kinase activity in rat striatum via thiol group oxidation. Neurotox Res 34:693–705. https://doi.org/10.1007/s12640-018-9934-y
Grings M et al (2019) ETHE1 and MOCS1 deficiencies: disruption of mitochondrial bioenergetics, dynamics, redox homeostasis and endoplasmic reticulum-mitochondria crosstalk in patient fibroblasts. Sci Rep 9:12651. https://doi.org/10.1038/s41598-019-49014-2
Halliwell B, Gutteridge J (2015) Oxidative stress and redox regulation: adaptation, damage, repair, senescence, and death. In: Halliwell B, Gutteridge JM (eds) Free radicals in biology and medicine, 5th edn. Oxford University Press Inc, New York, pp 199–283
Haskovic M et al (2019) Pathophysiology and targets for treatment in hereditary galactosemia: a systematic review of animal and cellular models. J Inherit Metab Dis. https://doi.org/10.1002/jimd.12202
Hildebrandt TM, Di Meo I, Zeviani M, Viscomi C, Braun HP (2013) Proteome adaptations in Ethe1-deficient mice indicate a role in lipid catabolism and cytoskeleton organization via post-translational protein modifications. Biosci Rep. https://doi.org/10.1042/BSR20130051
Hill BC, Woon TC, Nicholls P, Peterson J, Greenwood C, Thomson AJ (1984) Interactions of sulphide and other ligands with cytochrome c oxidase. An electron-paramagnetic-resonance study. Biochem J 224:591–600. https://doi.org/10.1042/bj2240591
Izzo V, Bravo-San Pedro JM, Sica V, Kroemer G, Galluzzi L (2016) Mitochondrial permeability transition: new findings and persisting uncertainties. Trends Cell Biol 26:655–667. https://doi.org/10.1016/j.tcb.2016.04.006
Jackson MR, Melideo SL, Jorns MS (2012) Human sulfide:quinone oxidoreductase catalyzes the first step in hydrogen sulfide metabolism and produces a sulfane sulfur metabolite. Biochemistry 51:6804–6815. https://doi.org/10.1021/bi300778t
Jiang J et al (2016) Hydrogen sulfide-mechanisms of toxicity and development of an antidote. Sci Rep 6:20831. https://doi.org/10.1038/srep20831
Kilic M, Dedeoglu O, Gocmen R, Kesici S, Yuksel D (2017) Successful treatment of a patient with ethylmalonic encephalopathy by intravenous N-acetylcysteine. Metab Brain Dis 32:293–296. https://doi.org/10.1007/s11011-016-9928-5
Kitzler TM, Gupta IR, Osterman B, Poulin C, Trakadis Y, Waters PJ, Buhas DC (2019) Acute and chronic management in an atypical case of ethylmalonic encephalopathy. JIMD Rep 45:57–63. https://doi.org/10.1007/8904_2018_136
Koumbadinga GA et al (2015) Increased stability of heterogeneous ribonucleoproteins by a deacetylase inhibitor. Biochim Biophys Acta 1849:1095–1103. https://doi.org/10.1016/j.bbagrm.2015.05.001
Landry AP, Moon S, Kim H, Yadav PK, Guha A, Cho US, Banerjee R (2019) A catalytic trisulfide in human sulfide quinone oxidoreductase catalyzes coenzyme a persulfide synthesis and inhibits butyrate oxidation. Cell Chem Biol 26(1515–1525):e1514. https://doi.org/10.1016/j.chembiol.2019.09.010
Leipnitz G et al (2003) Ethylmalonic acid inhibits mitochondrial creatine kinase activity from cerebral cortex of young rats in vitro. Neurochem Res 28:771–777
Leipnitz G, Vargas CR, Wajner M (2015) Disturbance of redox homeostasis as a contributing underlying pathomechanism of brain and liver alterations in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. J Inherit Metab Dis 38:1021–1028. https://doi.org/10.1007/s10545-015-9863-3
Leipnitz G et al (2018) Evaluation of mitochondrial bioenergetics, dynamics, endoplasmic reticulum-mitochondria crosstalk, and reactive oxygen species in fibroblasts from patients with complex I deficiency. Sci Rep 8:1165. https://doi.org/10.1038/s41598-018-19543-3
Lemasters JJ et al (1998) The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1366:177–196. https://doi.org/10.1016/s0005-2728(98)00112-1
Li C, Sun S, Park D, Jeong HO, Chung HY, Liu XX, Zhou HM (2011) Hydrogen peroxide targets the cysteine at the active site and irreversibly inactivates creatine kinase. Int J Biol Macromol 49:910–916. https://doi.org/10.1016/j.ijbiomac.2011.08.005
Lopez-Crisosto C et al (2015) ER-to-mitochondria miscommunication and metabolic diseases. Biochim Biophys Acta 1852:2096–2105. https://doi.org/10.1016/j.bbadis.2015.07.011
Marchi S, Pinton P (2014) The mitochondrial calcium uniporter complex: molecular components, structure and physiopathological implications. J Physiol 592:829–839. https://doi.org/10.1113/jphysiol.2013.268235
Mineri R et al (2008) Identification of new mutations in the ETHE1 gene in a cohort of 14 patients presenting with ethylmalonic encephalopathy. J Med Genet 45:473–478. https://doi.org/10.1136/jmg.2008.058271
Miyamoto Y et al (2015) Hypomyelinating leukodystrophy-associated missense mutation in HSPD1 blunts mitochondrial dynamics. Biochem Biophys Res Commun 462:275–281. https://doi.org/10.1016/j.bbrc.2015.04.132
Mnatsakanyan N, Beutner G, Porter GA, Alavian KN, Jonas EA (2017) Physiological roles of the mitochondrial permeability transition pore. J Bioenerg Biomembr 49:13–25. https://doi.org/10.1007/s10863-016-9652-1
Moran M et al (2010) Mitochondrial bioenergetics and dynamics interplay in complex I-deficient fibroblasts. Biochim Biophys Acta 1802:443–453. https://doi.org/10.1016/j.bbadis.2010.02.001
Nochi Z, Olsen RKJ, Gregersen N (2017) Short-chain acyl-CoA dehydrogenase deficiency: from gene to cell pathology and possible disease mechanisms. J Inherit Metab Dis 40:641–655. https://doi.org/10.1007/s10545-017-0047-1
Olsen RK, Cornelius N, Gregersen N (2013) Genetic and cellular modifiers of oxidative stress: what can we learn from fatty acid oxidation defects? Mol Genet Metab 110(Suppl):S31–39. https://doi.org/10.1016/j.ymgme.2013.10.007
Olsen RK, Cornelius N, Gregersen N (2015) Redox signalling and mitochondrial stress responses; lessons from inborn errors of metabolism. J Inherit Metab Dis 38:703–719. https://doi.org/10.1007/s10545-015-9861-5
Palikaras K, Lionaki E, Tavernarakis N (2018) Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat Cell Biol 20:1013–1022. https://doi.org/10.1038/s41556-018-0176-2
Palmfeldt J et al (2011) Proteomics reveals that redox regulation is disrupted in patients with ethylmalonic encephalopathy. J Proteome Res 10:2389–2396. https://doi.org/10.1021/pr101218d
Parmeggiani B, Vargas CR (2018) Oxidative stress in urea cycle disorders: findings from clinical and basic research. Clin Chim Acta 477:121–126. https://doi.org/10.1016/j.cca.2017.11.041
Pigeon N, Campeau PM, Cyr D, Lemieux B, Clarke JT (2009) Clinical heterogeneity in ethylmalonic encephalopathy. J Child Neurol 24:991–996. https://doi.org/10.1177/0883073808331359
Popov LD (2020) Mitochondrial biogenesis: an update. J Cell Mol Med. https://doi.org/10.1111/jcmm.15194
Rae CD, Broer S (2015) Creatine as a booster for human brain function. How might it work? Neurochem Int 89:249–259. https://doi.org/10.1016/j.neuint.2015.08.010
Richard E, Gallego-Villar L, Rivera-Barahona A, Oyarzabal A, Perez B, Rodriguez-Pombo P, Desviat LR (2018) Altered redox homeostasis in branched-chain amino acid disorders, organic acidurias, and homocystinuria. Oxid Med Cell Longev 2018:1246069. https://doi.org/10.1155/2018/1246069
Ritter L, Kleemann D, Hickmann FH, Amaral AU, Sitta A, Wajner M, Ribeiro CA (2015) Disturbance of energy and redox homeostasis and reduction of Na+, K+-ATPase activity provoked by in vivo intracerebral administration of ethylmalonic acid to young rats. Biochim Biophys Acta 1852:759–767. https://doi.org/10.1016/j.bbadis.2015.01.003
Rottenberg H, Hoek JB (2017) The path from mitochondrial ROS to aging runs through the mitochondrial permeability transition pore. Aging Cell 16:943–955. https://doi.org/10.1111/acel.12650
Sahebekhtiari N, Nielsen CB, Johannsen M, Palmfeldt J (2016) Untargeted metabolomics analysis reveals a link between ETHE1-mediated disruptive redox state and altered metabolic regulation. J Proteome Res 15:1630–1638. https://doi.org/10.1021/acs.jproteome.6b00100
Sahebekhtiari N, Fernandez-Guerra P, Nochi Z, Carlsen J, Bross P, Palmfeldt J (2019) Deficiency of the mitochondrial sulfide regulator ETHE1 disturbs cell growth, glutathione level and causes proteome alterations outside mitochondria. Biochim Biophys Acta Mol Basis Dis 1865:126–135. https://doi.org/10.1016/j.bbadis.2018.10.035
Salnikov DS, Makarov SV, van Eldik R, Kucherenko PN, Boss GR (2014) Kinetics and mechanism of the reaction of hydrogen sulfide with diaquacobinamide in aqueous solution. Eur J Inorg Chem 2014:4123–4133. https://doi.org/10.1002/ejic.201402082
Schuck PF et al (2002) Inhibition of creatine kinase activity in vitro by ethylmalonic acid in cerebral cortex of young rats. Neurochem Res 27:1633–1639. https://doi.org/10.1023/a:1021682910373
Schuck PF et al (2010) Promotion of lipid and protein oxidative damage in rat brain by ethylmalonic acid. Neurochem Res 35:298–305. https://doi.org/10.1007/s11064-009-0055-0
Schuck PF et al (2015) Brain and muscle redox imbalance elicited by acute ethylmalonic acid administration. PLoS ONE 10:e0126606. https://doi.org/10.1371/journal.pone.0126606
Seminotti B et al (2018) Mitochondrial energetics is impaired in very long-chain acyl-CoA dehydrogenase deficiency and can be rescued by treatment with mitochondria-targeted electron scavengers. Hum Mol Genet. https://doi.org/10.1093/hmg/ddy403
Sumien N, Shetty RA, Gonzales EB (2018) Creatine, creatine kinase, and aging. Subcell Biochem 90:145–168. https://doi.org/10.1007/978-981-13-2835-0_6
Szabo C (2007) Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6:917–935. https://doi.org/10.1038/nrd2425
Tam A et al (2019) Improved clinical outcome following liver transplant in patients with ethylmalonic encephalopathy. Am J Med Genet A 179:1015–1019. https://doi.org/10.1002/ajmg.a.61104
Tilokani L, Nagashima S, Paupe V, Prudent J (2018) Mitochondrial dynamics: overview of molecular mechanisms. Essays Biochem 62:341–360. https://doi.org/10.1042/EBC20170104
Tiranti V, Zeviani M (2013) Altered sulfide (H(2)S) metabolism in ethylmalonic encephalopathy. Cold Spring Harb Perspect Biol 5:a011437. https://doi.org/10.1101/cshperspect.a011437
Tiranti V et al (2006) ETHE1 mutations are specific to ethylmalonic encephalopathy. J Med Genet 43:340–346. https://doi.org/10.1136/jmg.2005.036210
Tiranti V et al (2009) Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. Nat Med 15:200–205. https://doi.org/10.1038/nm.1907
Truong DH, Eghbal MA, Hindmarsh W, Roth SH, O'Brien PJ (2006) Molecular mechanisms of hydrogen sulfide toxicity. Drug Metab Rev 38:733–744. https://doi.org/10.1080/03602530600959607
Vercesi AE, Castilho RF, Kowaltowski AJ, de Oliveira HCF, de Souza-Pinto NC, Figueira TR, Busanello ENB (2018) Mitochondrial calcium transport and the redox nature of the calcium-induced membrane permeability transition. Free Radic Biol Med 129:1–24. https://doi.org/10.1016/j.freeradbiomed.2018.08.034
Viscomi C et al (2010) Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy. Nat Med 16:869–871. https://doi.org/10.1038/nm.2188
Vockley J, Zschocke J, Knerr I, Vockley CW, Gibson KM (2013) Branched chain organic acidurias. The online metabolic & molecular bases of inherited disease. McGraw-Hill Education, New York
Wajner M (2019) Neurological manifestations of organic acidurias. Nat Rev Neurol 15:253–271. https://doi.org/10.1038/s41582-019-0161-9
Wajner M, Amaral AU (2015) Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies. Biosci Rep 36:e00281. https://doi.org/10.1042/BSR20150240
Wajner M, Goodman SI (2011) Disruption of mitochondrial homeostasis in organic acidurias: insights from human and animal studies. J Bioenergy Biomembr 43:31–38. https://doi.org/10.1007/s10863-011-9324-0
Wajner M, Amaral AU, Leipnitz G, Seminotti B (2019) Pathogenesis of brain damage in glutaric acidemia type I: lessons from the genetic mice model. Int J Dev Neurosci 78:215–221. https://doi.org/10.1016/j.ijdevneu.2019.05.005
Weissig V (2020) Drug development for the therapy of mitochondrial diseases. Trends Mol Med 26:40–57. https://doi.org/10.1016/j.molmed.2019.09.002
Wong HS, Dighe PA, Mezera V, Monternier PA, Brand MD (2017) Production of superoxide and hydrogen peroxide from specific mitochondrial sites under different bioenergetic conditions. J Biol Chem 292:16804–16809. https://doi.org/10.1074/jbc.R117.789271
Wu M, Gu J, Zong S, Guo R, Liu T, Yang M (2020) Research journey of respirasome. Protein Cell. https://doi.org/10.1007/s13238-019-00681-x
Wyse ATS, Grings M, Wajner M, Leipnitz G (2019) The role of oxidative stress and bioenergetic dysfunction in sulfite oxidase deficiency: insights from animal models. Neurotox Res 35:484–494. https://doi.org/10.1007/s12640-018-9986-z
Zafeiriou DI et al (2007) Ethylmalonic encephalopathy: clinical and biochemical observations. Neuropediatrics 38:78–82. https://doi.org/10.1055/s-2007-984447
Zhu J, Wang KZ, Chu CT (2013) After the banquet: mitochondrial biogenesis, mitophagy, and cell survival. Autophagy 9:1663–1676. https://doi.org/10.4161/auto.24135
Zorov DB, Juhaszova M, Sollott SJ (2014) Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev 94:909–950. https://doi.org/10.1152/physrev.00026.2013
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
MG, MW and GL worked in the conception, writing and revision of the article.
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that there are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Grings, M., Wajner, M. & Leipnitz, G. Mitochondrial Dysfunction and Redox Homeostasis Impairment as Pathomechanisms of Brain Damage in Ethylmalonic Encephalopathy: Insights from Animal and Human Studies. Cell Mol Neurobiol 42, 565–575 (2022). https://doi.org/10.1007/s10571-020-00976-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-020-00976-2